In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor vascular endothelial growth factor

被引:173
作者
Cao, YH
Linden, P
Shima, D
Browne, F
Folkman, J
机构
[1] HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT CELLULAR BIOL,BOSTON,MA 02115
[3] CHILDRENS HOSP,DEPT SURG,BOSTON,MA 02115
关键词
angiogenesis; placental growth factor; vascular endothelial growth factor;
D O I
10.1172/JCI119069
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To investigate the in vivo angiogenic activity of placenta growth factor (PIGF) and its heterodimers with vascular endothelial growth factor (VEGF), the induction of neovascularization of these factors in the mouse cornea was studied. VEGF(165) is sufficiently potent to stimulate new capillary growth from the limbal vessels. PIGF(129)/VEGF(165) heterodimers also induce corneal neovascularization with a maximal vessel length similar to VEGF(165), but with a marked decrease of vessel density. In contrast, PIGF(129) has little or no effect in this in vivo angiogenesis assay. The expression of VEGF mRNA and protein is drastically up-regulated by hypoxia in choriocarcinoma cells, whereas expression of PIGF is not affected by the low concentration of oxygen. Up-regulation of VEGF production results in increased formation of PIGF/VEGF heterodimers in these tumor cells. Thus, hypoxia indirectly up-regulates expression levels of PIGF/VEGF heterodimers and modulates VEGF activity when these factors are co-expressed.
引用
收藏
页码:2507 / 2511
页数:5
相关论文
共 31 条
[1]  
CAO Y, 1995, J EXP MED, V182, P2067
[2]   Heterodimers of placenta growth factor vascular endothelial growth factor - Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR [J].
Cao, YH ;
Chen, H ;
Zhou, L ;
Chiang, MK ;
AnandApte, B ;
Weatherbee, JA ;
Wang, YD ;
Fang, FY ;
Flanagan, JG ;
Tsang, MLS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3154-3162
[3]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[4]   PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER [J].
DISALVO, J ;
BAYNE, ML ;
CONN, G ;
KWOK, PW ;
TRIVEDI, PG ;
SODERMAN, DD ;
PALISI, TM ;
SULLIVAN, KA ;
THOMAS, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7717-7723
[5]   PITUITARY FOLLICULAR CELLS SECRETE A NOVEL HEPARIN-BINDING GROWTH-FACTOR SPECIFIC FOR VASCULAR ENDOTHELIAL-CELLS [J].
FERRARA, N ;
HENZEL, WJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :851-858
[6]   Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene [J].
Ferrara, N ;
CarverMoore, K ;
Chen, H ;
Dowd, M ;
Lu, L ;
OShea, KS ;
PowellBraxton, L ;
Hillan, KJ ;
Moore, MW .
NATURE, 1996, 380 (6573) :439-442
[7]   THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF POLYPEPTIDES [J].
FERRARA, N ;
HOUCK, KA ;
JAKEMAN, LB ;
WINER, J ;
LEUNG, DW .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :211-218
[8]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[9]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[10]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31